Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
UBE1C (UBA3) Monoclonal Antibody (OTI7H6), TrueMAB™, OriGene

Mouse Monoclonal Antibody
Supplier: OriGene CF811903


Description
UBE1C (UBA3) Monoclonal antibody specifically detects UBE1C (UBA3) in Human, Mouse, Rat samples. It is validated for Immunohistochemistry (Paraffin), Western BlotSpecifications
UBE1C (UBA3) | |
Monoclonal | |
See Label | |
PBS with 8% trehalose and no preservative; pH 7.3 | |
Q99MJ9, Q9BQ39 | |
Mouse | |
Protein A/G | |
RUO | |
361848, 79009, 94213 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG2b |
Immunohistochemistry (Paraffin), Western Blot | |
OTI7H6 | |
Unconjugated | |
DDX50 | |
A830034N06Rik; AI256736; AI848246; AW546539; DKFZp566J164; hUBA3; MGC22384; NAE2; NEDD8-activating enzyme E1 catalytic subuni-like protein; NEDD8-activating enzyme E1 catalytic subunit; NEDD8-activating enzyme E1 subunit 2; NEDD8-activating enzyme E1C; Nedd8-activating enzyme hUba3; Uba3; UBA3, ubiquitin-activating enzyme E1 homolog; UBE1C; ubiquitin like modifier activating enzyme 3; ubiquitin-activating enzyme 3; Ubiquitin-activating enzyme E1C; ubiquitin-activating enzyme E1C (homologous to yeast UBA3); ubiquitin-activating enzyme E1C (UBA3 homolog, yeast); ubiquitin-like modifier activating enzyme 3; ubiquitin-like modifier-activating enzyme 3; Unknown (protein for MGC:140052); wu:fb75e04; wu:fc37b11; zgc:55528 | |
Human recombinant protein fragment corresponding to amino acids 1-287 of human DDX50 (NP_076950) produced in E.coli. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Lyophilized |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction